• Galera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC

    29 June 2022
    Download

  • Aculys Pharma initiates collaboration with Ubie with the aim of building a “sleep ecosystem”

    29 June 2022
    Download

  • Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

    28 June 2022
    Download

  • Acrivon Therapeutics Receives FDA Clearance for Innovative Phase 2 Trial to Treat Ovarian, Endometrial and Urothelial Cancer Patients Based on Predicted Sensitivity to ACR-368

    22 June 2022
    Download

  • Galecto Announces First Patient Enrolled in Phase 2 Trial of GB1211 in Combination with Atezolizumab for First-Line Treatment of NSCLC

    16 June 2022
    Download

  • Dren Bio Announces $65 Million Series B Financing to Advance its Lead Asset into the Clinic

    14 June 2022
    Download

  • Innovationen in der Biotechnologie #1: Viel mehr als nur Impfstoffe

    13 June 2022
    Download

  • Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension

    8 June 2022
    Download

  • Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for USD 4.1 billion in cash

    3 June 2022
    Download

  • Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases

    2 June 2022
    Download

  • Galera Announces Oral Presentation at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Detailing Results from Phase 3 ROMAN Trial of Avasopasem

    26 May 2022
    Download

  • Experten Interview zu Biotechnologie: «Wir sind auf einem Niveau, das für einen Einstieg interessant ist»

    25 May 2022
    Download

  • Pfizer to acquire HBM portfolio company Biohaven Pharmaceuticals in USD 11.6 billion deal

    10 May 2022
    Download

  • NiKang Therapeutics and Hansoh Pharma Announce Strategic Collaboration and License Agreement for NKT2152 in Greater China

    3 May 2022
    Download

  • Galera Announces Topline Results from Phase 2a AESOP Trial of Avasopasem for Chemoradiotherapy-Induced Esophagitis

    2 May 2022
    Download

  • Galecto Completes Enrollment in Global Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of IPF

    26 April 2022
    Download

  • Die meisten Biotech-IPO sind unter Wasser

    20 April 2022
    Download

  • SWIXX and JAZZ expand partnership

    19 April 2022
    Download

  • SWIXX and Blueprint Medicines enter into CEE + Greece agreement for AYVAKYT® (avapritinib)

    11 April 2022
    Download

  • iTeos Presents New Data for Anti-TIGIT Antibody, EOS-448/GSK4428859A, at the AACR Annual Meeting 2022

    8 April 2022
    Download

  • Galecto Completes Enrollment in Phase 1b/2a GULLIVER-2 Trial of its Selective, Oral Galectin-3 Inhibitor GB1211 in Liver Cirrhosis

    29 March 2022
    Download

  • Aculys Pharma Closes US$24 Million Series B Financing Joined by Domestic and Foreign Investors

    28 March 2022
    Download

  • Streuung ist bei Biotechs das A und O

    16 February 2022
    Download

  • Pharmacy Marketplace 1000Farmacie Closes $15M Series A Financing Round Led by P101 SGR and HBM Healthcare Investments

    7 February 2022
    Download

  • NEURELIS Signs Exclusive Licensing Agreement with ACULYS PHARMA for the Development and Commercialization of VALTOCO® (DIAZEPAM NASAL SPRAY) in Japan and the Asia-Pacific Region

    25 January 2022
    Download
    • More news